Status:
UNKNOWN
Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells
Lead Sponsor:
University of Rostock
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Eye Diseases
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
The study analysis the influence of benzalkonium chloride on the density of antigen presenting Langerhans cells. This is achieved in a double blind randomized study using in-vivo confocal microscopy t...
Eligibility Criteria
Inclusion
- healthy probands
Exclusion
- eye diseases
- pregnancy and lactation period
- drug dependency
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00414739
Last Update
December 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rostock, Eye Department
Rostock, Germany, 18057